We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac MRI Improves Diagnosis in Patients with Life-Threatening Arrhythmias

By HospiMedica International staff writers
Posted on 01 Mar 2012
New research out of Canada has shown the benefits of performing cardiovascular magnetic resonance (CMR) imaging in instances where patients have been resuscitated after sudden cardiac death, or enter the hospital suffering from ventricular arrhythmias.

Cardiologist Dr. More...
James White and his colleagues from Western University’s (London, Ontario, Canada) Schulich School of Medicine & Dentistry, found CMR to be a very effective diagnostic imaging approach, identifying a cardiac diagnosis in 75% of cases compared with only 50% in all other testing. Overall, CMR identified a new or alternate explanation for the arrhythmia in 50% of patients. The findings were published in the January 2012 issue of Circulation: Cardiovascular Imaging, a journal of the American Heart Association.

The study assessed the impact of performing CMR in 82 consecutive patients that presented to hospital with either resuscitated sudden cardiac death or ventricular tachycardia. “In these cases, there is a fear of recurrence, so we want to identify what might be at the root of the heart rhythm,” explained Dr. White, the director of the cardiovascular MRI Clinical Research Program at Schulich’s Robarts Research Institute (London, Ontario, Canada).

Conventional cardiac imaging tests were performed in all patients. In addition, the researchers used a 3-Tesla MRI scanner at the Robarts Research Institute to assess whether they could determine the problem with one test. “What we found was interesting. In three-quarters of the patients who had an MRI performed, we were able to identify a plausible reason why that heart rhythm occurred.

When we looked at the conventional testing and in only half the patients found a cause. So this made a very big and incremental difference to our diagnosis of these patients. We also found that about 50% of the time, we provided either a new or alternate diagnosis for this patient population.”

The patients were frequently found to have inflammation of the heart muscle or small heart attacks that had gone undetected. The research was conducted in conjunction with the arrhythmia department at London Health Sciences Center (LHSC).

Related Links:

Western University
Schulich’s Robarts Research Institute



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.